Quantcast

Latest Cancer staging Stories

2014-08-08 11:22:18

OSA A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. The instrument, described in a paper published today in The Optical Society’s (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or...

2014-07-31 23:17:16

Virtual Staging LLC‘s new office space supports current and future growth in virtual home staging services. Stillwater, MN (PRWEB) July 31, 2014 Virtual Staging LLC, a leading provider of virtual home staging services, announces today the relocation to a new office space to accommodate the rapid growth and future expansion plans. The new office space located in the hearth of Stillwater, the 1848 birthplace of Minnesota on the scenic St. Croix River, will provide capacity for virtual...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

2014-05-27 08:29:47

Fully automated system effectively isolates and retrieves circulating tumour cells for timely, tailored treatment of cancer CHICAGO, May 27, 2014 /PRNewswire/ -- Clearbridge BioMedics will launch its ClearCell(® )FX System at the upcoming American Society of Clinical Oncology (ASCO) 2014 Annual Meeting. This is Clearbridge BioMedics' next-generation device that is able to isolate and capture circulating tumour cells (CTCs)[1] from a blood sample. This is crucial for both research...

2014-05-15 12:28:11

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., May 15, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($14.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-04-29 16:25:50

Blair, Ph.D., testifies how God enabled him to live cancer-free, without treatment MAITLAND, Fla., April 29, 2014 /PRNewswire-iReach/ -- In his new book, God's Cure For Cancer: No chemotherapy, No radiation, No surgery ($12.99, paperback, 9781629522029; $6.99, e-book, 9781629522036) Weston L. Blair, Ph.D. tells the remarkable story of how God healed him from Stage 4 Non-Hodgkin's Lymphoma. The author's full recovery was made possible only through the Word of God. Furthermore, he was...

2014-03-05 23:25:20

Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos. Raleigh, NC (PRWEB) March 05, 2014 A new published study of patients who had their bladders removed because of cancer suggests that the drug Actos may not have much effect on the growth and extent of cancer. As Cancer Monthly reports, the study, published in BMC Urology, examined the cases of...

2014-02-19 12:44:47

Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death. According to a study published in this week's PLOS Medicine by Anja Ulmer, Christoph Klein and colleagues from the Universities of Tübingen and Regensburg, Germany, the prognosis of a patient largely depends on the number of disseminated cancer cells per million lymphocytes in the sentinel node. Even very low numbers were found...

2014-02-11 04:22:13

NORTH BRUNSWICK, N.J., Feb. 11, 2014 /PRNewswire/ -- PDS Biotechnology Corp., a clinical-stage biotechnology company focused on the development of novel immunotherapy treatments for cancer and other chronic diseases, as well as novel preventive vaccines, today announced that the first patient has been successfully vaccinated with PDS0101 in a Phase 1 clinical trial in patients with cervical intraepithelial neoplasia. The trial which is being conducted at three leading gynecological...

2014-02-04 12:27:40

Program goal is improved understanding of individual risk for recurrence in patients diagnosed with early stage melanoma FRIENDSWOOD, Texas, Feb. 4, 2014 /PRNewswire/ -- Castle Biosciences Inc., a leading developer of diagnostic and prognostic tests for rare cancers, today announced the launch of an educational program dedicated to the information needs of Stage I and II skin (cutaneous) melanoma patients and their caregivers. The program kicks off with the launch of an animated...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'